Magnesium Sulfate Dosing in Aluminum Phosphide (Celphos) Poisoning
For adults with aluminum phosphide poisoning and cardiac instability or refractory hypotension, administer intravenous magnesium sulfate 1-2 g (8.1-16.2 mEq) as an initial bolus over 2-5 minutes, followed by continuous infusion to maintain serum magnesium >2.0 mmol/L. 1
Adult Dosing Protocol
Initial Bolus Dose
- Administer 1-2 g magnesium sulfate IV push (diluted in 10 mL D5W) for cardiac arrest, torsades de pointes, or polymorphic ventricular tachycardia with QT prolongation 2, 1
- This translates to 8.1-16.2 mEq or 4.05-8.1 mmol of magnesium 3
- Infuse over 2-5 minutes for acute cardiotoxicity 4, 5
Continuous Infusion Regimen
The most effective dosing schedule based on clinical research involves aggressive magnesium replacement 3, 6:
- Initial loading phase: 1 g magnesium sulfate IV bolus, then 1 g every hour for 3 consecutive hours 3
- Maintenance phase: 1 g every 6 hours for the next 24 hours 3
- Total first 24 hours: 30 mmol (approximately 7 g) 3
- Subsequent days: 16 mmol (4 g) daily until recovery or maximum 5 days 3
This higher-dose schedule (dose schedule No. 2) significantly reduced mortality compared to lower-dose regimens in aluminum phosphide poisoning 6. The aggressive dosing maintains magnesium levels persistently above normal, which correlates with improved survival 6.
Target Serum Levels
- Maintain serum magnesium ≥2.0 mmol/L throughout treatment 1
- Maintain serum potassium ≥4.0 mmol/L concurrently, as hypokalemia potentiates arrhythmias 1
- Monitor magnesium levels every 6 hours during the first 24 hours 3
Pediatric Dosing
For children with aluminum phosphide poisoning and cardiac arrest or severe cardiotoxicity:
- Initial bolus: 25-50 mg/kg IV/IO (maximum 2 g) over 10-20 minutes 2
- Alternatively, use the "rule of 6" for continuous infusion: 0.6 × body weight (kg) = mg of magnesium diluted to 100 mL saline; then 1 mL/h delivers 0.1 mcg/kg/min 7
Critical Safety Monitoring
Magnesium Toxicity Recognition
Patients with renal failure require dose reduction and intensive monitoring, as they can develop life-threatening magnesium toxicity at standard doses 1:
- Early signs: Flushing, sweating, hypotension 1
- Severe toxicity: AV block, bradycardia, respiratory paralysis, cardiac arrest 1
- Monitor deep tendon reflexes (loss indicates impending toxicity)
- Check renal function before initiating high-dose protocols
Immediate Reversal Agent
Keep calcium gluconate 10% (15-30 mL) or calcium chloride 10% (5-10 mL) at bedside for immediate IV administration if magnesium toxicity develops 4, 1. Calcium directly antagonizes magnesium's cardiac effects and can be life-saving 4.
Refractory Cases: Escalation Strategy
If cardiac arrhythmias persist despite adequate magnesium replacement 1:
- Increase heart rate with temporary transvenous pacing or isoproterenol infusion to suppress torsades de pointes 1
- Consider VA-ECMO for refractory cardiogenic shock or cardiac arrest unresponsive to maximal medical therapy including magnesium 5, 1
Mechanistic Rationale
Aluminum phosphide causes profound hypomagnesemia, which is consistently observed in poisoned patients and correlates with mortality 3, 6. The released phosphine gas inhibits cytochrome c oxidase, causing cellular hypoxia and myocardial dysfunction 8. Magnesium stabilizes cardiac membranes, reduces arrhythmias, and improves outcomes when serum levels are maintained above normal 6. Studies demonstrate mortality reduction from 52% without magnesium to significantly lower rates with aggressive magnesium replacement 3, 6.
Common Pitfalls to Avoid
- Do not use low-dose magnesium protocols (e.g., single 1-2 g bolus only) in aluminum phosphide poisoning, as they fail to maintain therapeutic levels and do not reduce mortality 6
- Do not delay magnesium administration while waiting for laboratory confirmation of hypomagnesemia, as levels drop rapidly and early treatment improves survival 3
- Do not administer magnesium as sole therapy—aggressive supportive care including fluid resuscitation, vasopressors, and sodium bicarbonate for metabolic acidosis remains essential 8, 9
- Avoid routine magnesium in undifferentiated cardiac arrest without evidence of aluminum phosphide poisoning or torsades de pointes, as it provides no benefit 2